Q1 2021 Holdings
Filed 2021-05-17 | 355 holdings | $19.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BlackRock Cap Invt Corp(BKCCUSD) | COM | 092533108 | $236 | 70,427 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $237 | 6,849 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $237 | 6,830 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $238 | 5,361 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $244 | 24,419 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $244 | 4,769 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $244 | 2,003 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $247 | 5,761 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $248 | 12,515 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $249 | 12,095 | 0.0% |
| Monroe Cap Corp(MRCC) | COM | 610335101 | $250 | 24,915 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $252 | 5,819 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $253 | 2,537 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $254 | 6,753 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $255 | 7,478 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $256 | 3,110 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $256 | 12,457 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $258 | 7,326 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $259 | 26,201 | 0.0% |
| Stellus Cap Invt Corp(SCM) | COM | 858568108 | $260 | 20,469 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $262 | 2,308 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $263 | 3,434 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $263 | 28,463 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $264 | 11,828 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $264 | 67,781 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $267 | 43,267 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $267 | 33,042 | 0.0% |
| Inovio Pharmaceuticals Inc | COM NEW | 45773H201 | $268 | 28,845 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $269 | 11,351 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $269 | 12,476 | 0.0% |
| CUE Biopharma Inc(CUE) | COM | 22978P106 | $269 | 22,053 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $273 | 172,591 | 0.0% |
| Xbiotech Inc(XBIT) | COM | 98400H102 | $273 | 15,872 | 0.0% |
| Oyster PT Pharma Inc | COM | 69242L106 | $274 | 14,995 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $274 | 17,856 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $275 | 12,381 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $275 | 3,686 | 0.0% |
| Voya Prime Rate TR | SH BEN INT | 92913A100 | $276 | 59,445 | 0.0% |
| Eaton Vance Fltg Rate Incom | COM SHS BEN INT | 278284104 | $278 | 17,104 | 0.0% |
| Eaton Vance SR Income TR(EVF) | SH BEN INT | 27826S103 | $280 | 42,193 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $280 | 6,486 | 0.0% |
| Oxford Square Cap Corp(OXSQ) | COM | 69181V107 | $281 | 60,656 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $282 | 6,543 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $282 | 22,244 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $283 | 44,755 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $285 | 15,414 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $285 | 2,480 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $288 | 22,950 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $290 | 2,480 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $291 | 10,016 | 0.0% |